NxStage Medical, Inc.: 10-Q filed 2018-08-07
What NxStage Medical, Inc. reported in its quarterly report filed 2018-08-07 (fiscal Q2 2018): 36 published measures, 102 facts as tagged in accession 0001333170-18-000010.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-08-07
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001333170-18-000010 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NxStage Medical, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 336,836,000 | USD | |
| At 2017-12-31 | 325,629,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 115,566,000 | USD | |
| At 2017-12-31 | 112,648,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 220,826,000 | USD | |
| At 2017-12-31 | 213,158,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 76,287,000 | USD | |
| At 2017-12-31 | 64,928,000 | USD | |
| At 2017-06-30 | 62,839,000 | USD | |
| At 2016-12-31 | 59,632,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -2,589,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -4,048,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,089,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -3,278,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 2,241,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 4,933,000 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 106,970,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 214,268,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -419,680,000 | USD | |
| At 2018-01-01 | -415,632,000 | USD | |
| At 2017-12-31 | -421,593,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 372,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 636,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -22,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -635,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 55,484,000 | USD | |
| At 2017-12-31 | 60,262,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -1,089,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -2,219,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,056,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -3,737,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 169,421,000 | USD | |
| At 2017-12-31 | 153,374,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 50,389,000 | USD | |
| At 2017-12-31 | 47,430,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 14,958,000 | USD | |
| At 2017-12-31 | 14,785,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 42,748,000 | USD | |
| At 2017-12-31 | 42,748,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 6,639,000 | USD | |
| At 2017-12-31 | 7,660,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 34,506,000 | USD | |
| At 2018-01-01 | 36,044,000 | USD | |
| At 2017-12-31 | 31,625,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 47,036,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 94,331,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 43,222,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 86,093,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 50,318,000 | USD | |
| At 2017-12-31 | 49,212,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 45,947,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 92,112,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 41,166,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 82,356,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 10,593,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 20,031,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 9,027,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 18,535,000 | USD | 181 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | -4,578,000 | USD | |
| At 2017-12-31 | -3,673,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 221,467,000 | USD | |
| At 2017-12-31 | 213,146,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 6,203,000 | USD | |
| At 2018-01-01 | 6,290,000 | USD | |
| At 2017-12-31 | 5,911,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 17,164,000 | USD | |
| At 2017-12-31 | 17,824,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 31,147,000 | USD | |
| At 2017-12-31 | 27,985,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-06-30 | 8,310,000 | USD | |
| At 2018-01-01 | 9,504,000 | USD | |
| At 2017-12-31 | 7,609,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -1,849,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -3,383,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,601,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -4,755,000 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -2,221,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -4,019,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -2,579,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -4,120,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -4,653,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -4,953,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -395,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 1,321,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | 9,751,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 20,211,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | 9,668,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 18,618,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -672,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -967,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -321,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -591,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-04-01 to 2018-06-30 | -760,000 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -1,164,000 | USD | 181 |
| 2017-04-01 to 2017-06-30 | -545,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -1,018,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | -1,379,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | -607,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 12,744,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 15,160,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-06-30 | 363,000 | USD | 181 |
| 2017-01-01 to 2017-06-30 | 401,000 | USD | 181 |
Inspect the source
- Entity
- NxStage Medical, Inc. / CIK 0001333170
- Captured
- SEC response SHA-256
94fc74ed70c77b6fca91c2f2b3ce858c15fa17ad9b34e5d833a969ac50d1d460
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001333170.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))